<DOC>
	<DOC>NCT01613456</DOC>
	<brief_summary>The main purpose of this study is the effect of the probiotic yeast Saccharomyces cerevisiae CNCM I-3856 on abdominal pain or intestinal discomfort in patients presenting with the irritable bowel syndrome (IBS)</brief_summary>
	<brief_title>Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Inclusion criteria: IBS subject meeting the Rome III criteria , with a discomfort or pain present more than 1 day per week in whom organic causes of their symptoms have been excluded IBSC with less than 3 complete spontaneous bowel movements/week IBSD with at least 2 or more days/week one stool which has consistency of type 6 or 7 Bristol stool score Subject able of and willing to comply with the protocol and to give their written informed consents Exclusion criteria: History of chronic gastrointestinal disorders History of lactose intolerance History of gluten intolerance Treatment able to influence IBS, modifying intestinal sensitivity and motility (antidepressants,opioid, narcotic analgesics) Eating disorders Pregnancy in progress</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>